Pfm Health Sciences, LP Gritstone Bio, Inc. Transaction History

Pfm Health Sciences, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$9.2 - $15.7 $3.45 Million - $5.88 Million	-374,656 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$9.97 - $18.96 $6.29 Million - $12 Million	-630,957 Reduced 62.74%	374,656 $4.98 Million
Q4 2018 Feb 14, 2019	SELL	$11.61 - $31.1 $693,117 - $1.86 Million	-59,700 Reduced 5.6%	1,005,613 $14.3 Million
Q3 2018 Nov 13, 2018	BUY	$14.24 - $14.24 $15.2 Million - $15.2 Million	1,065,313 New	1,065,313 $14.3 Million

1.2M

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

Stay updated on Pfm Health Sciences, LP with notifications on news.